You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recombinant Non-immunogenic Staphylokinase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Moscow (Recombinant nonimmunogenic staphylokinase, Placebo)

Suspended
  • COVID-19
  • Recombinant nonimmunogenic staphylokinase
  • Placebo
  • Moscow, Russian Federation
  • +1 more
Oct 25, 2022

Acute Limb Ischemia Trial in Russian Federation (Recombinant non-immunogenic staphylokinase (Fortelyzin®), surgical methods of

Recruiting
  • Acute Limb Ischemia
  • Recombinant non-immunogenic staphylokinase (Fortelyzin®)
  • surgical methods of treatment
  • Kazan, Republic Of Tatarstan, Russian Federation
  • +5 more
Jan 19, 2023

Massive Pulmonary Embolism Trial in Russian Federation (Recombinant nonimmunogenic staphylokinase, Alteplase)

Recruiting
  • Massive Pulmonary Embolism
  • Recombinant nonimmunogenic staphylokinase
  • Alteplase
  • Barnaul, Russian Federation
  • +16 more
Feb 7, 2022

Acute Stroke Trial in Saint-Petersburg

Not yet recruiting
  • Acute Stroke
    • Saint-Petersburg, Russian Federation
      St. Petersburg Research Institute of Emergency Medicine named af
    Jan 14, 2023

    Platelet Membrane Cloaked Recombinant Staphylokinase on Human

    Not yet recruiting
    • Arterial Thrombosis
    • collection of venous blood or arterial blood
    • (no location specified)
    Aug 6, 2023

    Norovirus Infections, Norwalk Gastroenteritis Trial (Human Norovirus Bivalent (G?.1/G?.4)Vaccine,Recombinant (Hansenula

    Not yet recruiting
    • Norovirus Infections
    • Norwalk Gastroenteritis
    • Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha)
    • placebo
    • (no location specified)
    Jun 14, 2023

    Ischemic Stroke Trial in Russian Federation (Recombinant staphylokinase, Alteplase)

    Completed
    • Ischemic Stroke
    • Barnaul, Russian Federation
    • +17 more
    Dec 11, 2020

    Acute Myocardial Infarction Trial in Bangalore, Agra, Kolkata (THR-100, Streptokinase)

    Completed
    • Acute Myocardial Infarction
    • Bangalore, Karnataka, India
    • +3 more
    Feb 22, 2021

    COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))

    Recruiting
    • COVID-19
    • Recombinant new coronavirus vaccine (CHO cell)
    • Changsha, Hunan, China
      Hunan Provincial Center for Disease Control and Prevention
    Oct 10, 2022

    SARS-CoV-2 Infection Trial in Mexico (AVX-COVID/12, ChAdOx-1-S[recombinant])

    Recruiting
    • SARS-CoV-2 Infection
    • AVX-COVID/12
    • ChAdOx-1-S[recombinant]
    • Mexico City, Cdmx, Mexico
    • +13 more
    Feb 3, 2023

    ST-segment Elevation Myocardial Infarction (STEMI) Trial in China (Recombinant Staphylokinase, Normal Saline)

    Active, not recruiting
    • ST-segment Elevation Myocardial Infarction (STEMI)
    • Recombinant Staphylokinase
    • Normal Saline
    • Nanjing, Jiangsu, China
    • +7 more
    Jan 30, 2023

    HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

    Not yet recruiting
    • HIV Infections
    • sD-NP-GT8 DNA
    • +4 more
    • Birmingham, Alabama
    • +5 more
    Mar 10, 2023

    Shingles, Zoster Trial in Geneva, (recombinant zoster vaccine)

    Not yet recruiting
    • Shingles
    • Zoster
    • recombinant zoster vaccine
    • Geneva,, Switzerland
      University Hospitals of Geneva
    Oct 24, 2022

    Vaccine Reaction, Vaccine Adverse Reaction Trial (SARS-CoV-2 Protein Subunit Recombinant Vaccine, Active Comparator)

    Recruiting
    • Vaccine Reaction
    • Vaccine Adverse Reaction
    • SARS-CoV-2 Protein Subunit Recombinant Vaccine
    • Active Comparator
    • Denpasar, Bali, Indonesia
    • +9 more
    Dec 12, 2022

    Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta

    Not yet recruiting
    • Vaccine Reaction
    • COVID-19
    • Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
    • VidPrevtyn® Beta vaccine (Sanofi/GSK)
    • Paris, France
      CIC 1417 Cochin-Pasteur
    Feb 28, 2023

    Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo

    Not yet recruiting
    • Colorectal Adenocarcinoma
    • +2 more
    • Trondheim, Trondelag, Norway
    • +2 more
    Aug 15, 2022

    Acute Myocardial Infarction Trial in Nanjing (Recombinant staphylokinase, Normal saline)

    Not yet recruiting
    • Acute Myocardial Infarction
    • Recombinant staphylokinase
    • Normal saline
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Jul 11, 2022

    Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

    Recruiting
    • Advanced Solid Tumor
    • Refractory Tumor
    • Radiotherapy
    • +4 more
    • Suzhou, China
      The Second Affiliated Hospital of SchoowUniversity
    Sep 14, 2023

    Coronavirus Disease 2019 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell) group)

    Completed
    • Coronavirus Disease 2019
    • Recombinant new coronavirus vaccine (CHO cell) group
    • Changsha, Hunan, China
      Hunan Provincial Center for Disease Control and Prevention
    Oct 21, 2021

    Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)

    Not yet recruiting
    • Lymphoma
    • Changchun, Jilin, China
      The First Bethune Hospital of Jilin University
    Apr 18, 2023

    HIV Trial in Rochester, Seattle (gp160 Vaccine (Immuno-AG), rgp120/HIV-1IIIB, rgp120/HIV-1MN)

    Completed
    • HIV Infections
    • gp160 Vaccine (Immuno-AG)
    • +4 more
    • Rochester, New York
    • +1 more
    Oct 28, 2021

    Infertility Trial in Guangzhou (GenSci094, Placebo RecFSH / follitropin alfa, Biological: RecFSH / Follitropin alfa (Days 1 to

    Recruiting
    • Infertility
    • Guangzhou, Guangdong, China
      The Sixth Affiliated Hospital, Sun Yat-sen University Guangdong
    Oct 17, 2023

    Lymphoma, Non-Hodgkin, Lymphoma, T-Cell Trial in Najing (Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Lymphoma, T-Cell
    • Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection
    • Najing, Jiangsu, China
      Jiangsu Provincial People's Hospital
    Sep 26, 2022

    Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

    Recruiting
    • Untreated Advanced Non-small Cell Lung Cancer
    • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
    • Fuzhou, Fujian, China
      Fujian Cancer Hospital
    Nov 13, 2023

    Severe Hemophilia A Trial in China (FRSW117)

    Not yet recruiting
    • Severe Hemophilia A
    • Beijing, China
    • +27 more
    Nov 16, 2023